Inhibition of Membrane-Type 1 Matrix Metalloproteinase by Hydroxamate Inhibitors: An Examination of the Subsite Pocket-Reference-Cited by-同舟云学术

Inhibition of Membrane-Type 1 Matrix Metalloproteinase by Hydroxamate Inhibitors: An Examination of the Subsite Pocket

Published:1998-03-21 Issue:8 Volume:41 Page:1209-1217
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Yamamoto Minoru¹,Tsujishita Hideki¹,Hori Noriyuki¹,Ohishi Yuichi¹,Inoue Shintaro¹,Ikeda Shoji¹,Okada Yasunori¹

Affiliation:

1. New Drug Discovery Research Laboratory, Kanebo Ltd., 1-5-90 Tomobuchi-Cho, Miyakojima-Ku, Osaka 534, Japan, Basic Science Laboratory, Kanebo Ltd., 5-3-28 Kotobuki-Cho, Odawara, Kanagawa 250, Japan, and Department of Molecular Immunology and Pathology, Cancer Research Institute, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa 920, Japan

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm970404a

Reference33 articles.

1. Tumor Cell Interactions with the Extracellular Matrix During Invasion and Metastasis

2. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate

3. A matrix metalloproteinase expressed on the surface of invasive tumour cells

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico identification of dual HDAC8 and MMP9 inhibitors by pharmacophore modeling, molecular docking, and molecular dynamics simulation studies for development of antitumour agent;Interactions;2024-08-29

2. Guiding bone cell network formation in 3D via photosensitized two-photon ablation;Acta Biomaterialia;2024-01

3. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment;International Journal of Molecular Sciences;2023-07-28

4. Functional mass nanoprobes inserted on live cells for in situ monitoring multiple secreted enzymes with MALDI-TOF mass spectrometry;Nano Today;2023-06

5. Targeted delivery of a colchicine analogue provides synergy with ATR inhibition in cancer cells;Biochemical Pharmacology;2022-07